oxamyl has been researched along with Apoplexy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aja, T; Allegrini, PR; Deckwerth, TL; Diaz, JL; Hengerer, B; Herrmann, J; Jahangiri, KG; Kallen, J; Karanewsky, DS; Linton, SD; Meduna, SP; Nalley, K; Robinson, ED; Roggo, S; Rovelli, G; Sauter, A; Sayers, RO; Schmitz, A; Smidt, R; Ternansky, RJ; Tomaselli, KJ; Ullman, BR; Wiessner, C; Wu, JC | 1 |
1 other study(ies) available for oxamyl and Apoplexy
| Article | Year |
|---|---|
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.
Topics: Apoptosis; Carbamates; Caspase Inhibitors; Cell Line; Dipeptides; Humans; Inhibitory Concentration 50; Kinetics; Neurodegenerative Diseases; Stroke; Structure-Activity Relationship | 2004 |